Evolution of the Average Target: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Evolution of the Average Target - Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Evolution of the Target Price: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Evolution of the Target Price - Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Changes in Analyst Recommendations: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

02cfefb07b0e9159c75f102f04b3d.3M2uLsCyPdjksvrD0-XvwYYIrgo2m8-T_NA41e0SnO4.kKbAFonqV7fS1Yqw67OWj_BnxltFq6DYi75igtVR793op8l88f1Jsr7lqw~abd2cecc41849ddef90b7d9a7309f3e5

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - -
+4.27%
+4.92%
-0.68%
-2.56%
+13.62%
-2.85%
+22.47%
-10.64%
+0.95%
Average +3.28%
Weighted average by Cap. +3.54%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
40.86
Average target price
-

Analyst Consensus Detail

Analyst consensus - Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
  1. Stock Market
  2. Stocks
  3. 600329 Stock
  4. Consensus Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited